Results 201 to 210 of about 1,322,570 (292)

A Phase 1 Study of the Pharmacokinetics, Safety, and Tolerability of Posdinemab (JNJ‐63733657) in Healthy Chinese Adults

open access: yesThe Journal of Clinical Pharmacology, EarlyView.
Abstract Posdinemab, a humanized immunoglobulin G1/κ monoclonal antibody, binds with high affinity to phosphorylated tau protein which is associated with Alzheimer's disease (AD) pathophysiology. Posdinemab reduced tau seeding in murine models and was well tolerated in Phase‐1 clinical studies.
Fangfang Wang   +7 more
wiley   +1 more source

Deep impact of COVID-19 in the healthcare of Latin America: the case of Brazil

open access: yesBrazilian Journal of Infectious Diseases, 2020
Sergio Cimerman   +3 more
doaj   +1 more source

Exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the endangered Iberian lynx (Lynx pardinus)

open access: hybrid
Javier Caballero‐Gómez   +12 more
openalex   +1 more source

The efficacy of an online self‐administered single session intervention to promote growth mindset in adolescents: A randomised controlled trial

open access: yesJCPP Advances, EarlyView.
We examined the efficacy of an online growth mindset single session intervention (SSI) for young people aged 14–18 years old in the UK. 104 participants were randomised to a registered clinical trial. Intention‐to‐treat analysis yielded negligible effect sizes for anxiety and depression symptoms, whereas the effect on personality mindset was ...
Jessica Ball   +7 more
wiley   +1 more source

Structural Analysis of Inhibitor Binding to the Feline Enteric Coronavirus (FECV) Main Protease. [PDF]

open access: yesViruses
Maryam A   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy